Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Therapeutics Issues Statement on Whistle-Blower Proceeding Status Oct 03, 2006 Zelos and Nektar Announce Start of Phase 1 Trial of Inhaled Ostabolin-C(TM) for Osteoporosis Sep 21, 2006 CORRECTING and REPLACING Zelos and Nektar Announce Start of Phase 1 Trial of Inhaled Ostabolin-C(TM) for Osteoporosis Sep 21, 2006 European Commission Grants Orphan Medicinal Product Designation to Nektar's Amphotericin B Inhalation Powder (ABIP) for the Prevention of Pulmonary Fungal Infections in Patients Deemed At Risk Sep 18, 2006 Nektar Reports that Pfizer Announced New Analyses Showing that Exubera Is Effective in Diabetes Patients Who Have Respiratory Infections or Who are Exposed to Passive Cigarette Smoke Sep 14, 2006 Exubera Hailed as Innovation in Prestigious European and American Awards Sep 12, 2006 Nektar to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medtech Conference, Oppenheimer Diabetes Conference and UBS Investment Bank 2006 Global Life Sciences Conference Sep 11, 2006 Nektar Announces Second Quarter 2006 Results Aug 03, 2006 Nektar Closes Its Bradford UK Site; Company Focusing on Development of Products Using its Drug Delivery Technology Jul 26, 2006 Nektar Announces Receipt of $17.6 Million Payment From Affymax, Inc. Under Agreement for Nektar Advanced PEGylation Technology; Cash Payment Resulting From Affymax and Takeda Signing Global Agreement for Hematide(TM) for the Treatment of Anemia Jul 24, 2006 Pagination First page « first Previous page ‹ previous … Page 47 Page 48 Page 49 Page 50 Page 51 Current page 52 Page 53 Page 54 Page 55 Next page next › Last page last »